Maureen Newman is a researcher by trade, and brings her knowledge of the lab to BioNews Texas. Currently, she is serving as a PhD student at University of Rochester, and working towards a career of research in biomaterials for drug delivery and regenerative medicine. She is an integral part of Dr. Danielle Benoit’s laboratory, where she is investigating bone-homing therapeutics for osteoporosis treatment. She is a senior science and research columnist for BioNews Texas.
Experiments that produce unexpected results are often times more informative than predictable experiments. Such is the case for a new study that found an unexpected link between the protein ... Read more
Researchers studying characteristics of cells isolated from muscular dystrophy patients may have found a new target to develop precision medicine. The research team found that certain molecules are increased ... Read more
While groundbreaking discoveries rooted in the laboratory are making progress in treating children with Duchenne muscular dystrophy (DMD), acupuncture and Traditional Chinese Medicine (TCM) also hold potential to help ... Read more
To help alleviate the long-term adverse effects of glucocorticoids in patients with Duchenne muscular dystrophy (DMD), a research team at Sapienza University of Rome is investigating a new form ... Read more
Stem cell therapy may be an interesting approach to treat Duchenne muscular dystrophy patients who also have Diamond-Blackfan anemia. A research team from the Department of Haematology & Bone ... Read more
Patients with facial paralysis as a result of muscular dystrophy may benefit from new research conducted at Johns Hopkins University School of Medicine. Kofi Boahene, MD, a facial plastic ... Read more
Muscle wasting in muscular dystrophy may be repairable using a new approach developed by a collaboration among researchers in Italy, Israel, and the United Kingdom. Published in EMBO Molecular ... Read more